Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 298 entries
View as:

Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02729194 Org: User:
Start: 06/30/16 End: 09/30/17 Due: 09/30/18

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00156273 Org: User:
Start: 04/30/05 End: 10/31/08 Due: 10/31/09

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00143845 Org: User:
Start: 04/30/03 End: 02/28/13 Due: 02/28/14

Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00135200 Org: User:
Start: 08/31/05 End: 09/04/24 Due: 09/04/25

The ConnectedCancerCare Pilot Study (CCC)

Phase: N/A Priority: Normal
NCT ID: NCT03618017 Org: User:
Start: 08/08/18 End: 08/30/19 Due: 08/30/20

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04076579 Org: User:
Start: 03/17/20 End: 01/31/25 Due: 01/31/26

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03785873 Org: User:
Start: 05/22/19 End: 11/15/24 Due: 11/15/25

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02031250 Org: User:
Start: 02/28/14 End: 12/31/23 Due: 12/31/24

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00995488 Org: User:
Start: 10/31/09 End: 11/30/13 Due: 11/30/14

Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03240016 Org: User:
Start: 02/08/18 End: 06/23/23 Due: 06/23/24

Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00645359 Org: User:
Start: 11/30/06 End: 04/30/14 Due: 04/30/15

The Validation of a Novel Adherence Method for Oral Oncolytics

Phase: N/A Priority: Normal
NCT ID: NCT03561272 Org: User:
Start: 06/20/17 End: 10/31/18 Due: 10/31/19

Curcumin for the Prevention of Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00027495 Org: User:
Start: 12/31/01 End: 09/30/07 Due: 09/30/08

Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC

Phase: N/A Priority: Normal
NCT ID: NCT00156286 Org: User:
Start: 03/31/02 End: 04/30/06 Due: 04/30/07

Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Phase: N/A Priority: Normal
NCT ID: NCT02677948 Org: User:
Start: 10/31/16 End: 10/31/18 Due: 10/31/19

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Phase: N/A Priority: Normal
NCT ID: NCT05038332 Org: User:
Start: 11/12/21 End: 11/30/29 Due: 11/30/30

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT01700036 Org: User:
Start: 07/31/13 End: 10/26/18 Due: 10/26/19

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02331368 Org: User:
Start: 06/30/15 End: 06/30/17 Due: 06/30/18

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00726375 Org: User:
Start: 05/31/08 End: 09/30/14 Due: 09/30/15

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00580983 Org: User:
Start: 08/31/03 End: 06/30/10 Due: 06/30/11

Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT06927947 Org: User:
Start: 08/30/25 End: 08/30/26 Due: 08/30/27

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00176800 Org: User:
Start: 11/30/01 End: 05/31/13 Due: 05/31/14

Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04094844 Org: User:
Start: 09/08/20 End: 08/11/24 Due: 08/11/25

Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00176735 Org: User:
Start: 12/31/01 End: 08/31/05 Due: 08/31/06

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03099356 Org: User:
Start: 04/27/17 End: 12/31/26 Due: 12/31/27